Close

CHRM1 Membrane Protein Introduction

Introduction Related Products Customer Reviews Customized Production Drug Discovery

Introduction of CHRM1

Protein Name Cholinergic receptor muscarinic 1
Gene Name CHRM1
Uniprot P11229 (Human); P12657 (Mouse)
Synonym M1; HM1; M1R; muscarinic acetylcholine receptor M1; acetylcholine receptor, muscarinic 1
Background CHRM1, encoded by CHRM1 gene, is a member of G protein-coupled receptors family. It is coupled with G proteins of class Gq and possesses seven transmembrane domain. The protein is a muscarinic receptor that is used as a therapeutic target for treatment of Alzheimer disease. And many therapeutic drugs and other substances are made by selecting CHRM1 as agonists or antagonists.

CHRM1 Related Products

Membrane Protein Products

Creative Biolabs offers comprehensive range of membrane protein products empowers your unique research needs.

CAT# Product Name Expression System Protein Length Solubilizing Agents
S01YF-1023-KX335 NativeExtract™ Human CHRM1 Membrane Protein (Full length, Super Nanodisc) HEK293 cells Full length Native Nanodisc
MPX3589K MemDX™ Membrane Protein Human CHRM1 Expressed in vitro E.coli expression system, Full Length E.coli cell-free Full length Detergent
Please contact us for more products or customization

Customer Reviews

S**a: Their team of scientists is not only highly knowledgeable but also incredibly responsive. They were always available to address my questions and concerns, providing detailed explanations and guidance whenever needed.

23/Sep/2023

D*n: The customized solutions they provided were perfectly tailored to our specific needs, and their attention to detail was remarkable.

17/Jul/2024

Customized Membrane Protein Production

Different membrane protein formats (Creative Biolabs Original)

CHRM1 Drug Discovery and Development

CHRM1 Small Molecule Drug Development

Small molecule drug development services (Creative Biolabs Original)

Anti-CHRM1 Antibody Discovery

Processes of antibody discovery (Creative Biolabs Original)

CHRM1 Gene Therapy Development

We provide tailored solutions to meet your specific requirements. Please inquire us for more services.

Gene Expression Comparison

Creative Biolabs offers gene expression comparison services. An initial investigation centered on the transcriptional landscape within the cerebral cortex of mice genetically deficient in the cholinergic receptor muscarinic 1 (Chrm1-/-). The resultant alterations in gene expression profiles were subsequently juxtaposed with analogous transcriptomic variations documented in individuals diagnosed with schizophrenia. Furthermore, in a distinct analytical thrust, those genes exhibiting modified expression levels within the Chrm1-/- murine model underwent rigorous comparative analysis against genetic loci robustly associated with human cognitive capabilities, as previously delineated by comprehensive genome-wide association studies.

CHRM1 Cell Therapy Discovery

Creative Biolabs offers comprehensive and innovative services to drive the development of CHRM1 cell therapy. Please inquire with us for more services.

Lentiviral Knockdown Models

Creative Biolabs offers lentiviral knockdown models development services. Lentiviral transduction was systematically employed to engineer prostate carcinoma cell lines exhibiting attenuated expression of both CHRM1 and Atg5. To achieve this targeted gene silencing, the designated cells underwent transduction with lentiviral constructs. These constructs were specifically designed to deliver short hairpin RNAs (shRNAs) capable of recognizing and mediating the degradation of CHRM1 and Atg5 messenger RNA transcripts. Subsequent to this genetic manipulation, the application of puromycin served as a stringent selection method, facilitating the isolation and ensuing propagation of stable cell populations that had successfully integrated the shRNA sequences.

Phenotypic Screening

Creative Biolabs offers phenotypic screening services. The functional interrogation of the CHRM1 gene, pursued through a phenotypic screening paradigm, initially involved the polymerase chain reaction (PCR)-based amplification of its coding sequence directly from genomic DNA templates. This amplified genetic material was subsequently engineered for heterologous expression within selected mammalian cellular systems. Such a methodological approach proved instrumental. It specifically enabled the delineation of putative pharmacological targets related to CHRM1 function and, furthermore, provided a framework for assessing the consequential repercussions of their potential modulation on fundamental cellular physiology.


All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us